Pitfalls and opportunities in quantitative fluorescence-based nanomedicine studies - A commentary

Jens B Simonsen1, Emil B Kromann2

  • 1Department of Health Technology, Section for Biotherapeutic Engineering and Drug Targeting, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kgs. Lyngby, Denmark.

Summary

Quantitative fluorescence imaging of nanomedicine is crucial but often flawed. This commentary highlights pitfalls like solvent interactions and fluorophore dissociation, offering guidelines for accurate nanomedicine targeting studies.